GSK believes innovation starts when you stop to listen. That's why GSK and Veeve Health

Care have partnered with the HIV community for decades and developed medicines that better

fit the lives of people living with HIV. That's just one example of how GSK unites science,

technology, and talent to get ahead of disease together. Visit gsk.com to learn more.

I'm Scott Galloway and this is No Mercy, No Malice. Metas Twitter competitor Threads

is the most ascendant platform in history. Disruption isn't a function of the disruptor,

but the disruptee. Threadzilla as read by George Han.

Last week, Twitter became MySpace. A social network void of innovation being slowly

euthanized by Meta. In less than a week, Meta's Threads registered 110 million users,

equivalent to the combined population of Germany and Australia and the most violent corporate

disruption in platform history. What can be learned? The business strategy that marked 2023

is not leveraging AI or adopting hybrid work, but focusing on bloat, specifically how to reduce it.

Whether you're a critic or a stan, Elon's 80% reduction in the bird's workforce

is the most impactful business decision of the year. The Zuck may have coined the phrase

the year of efficiency, but it was Elon who inspired the movement.

It turns out you don't need all that many people to run Twitter.

The result is the NASDAQ's best first half in four decades, fueled by the nitro and glycerin

of AI hype and profits increasing, thanks mostly to cost cutting. A new generation of business leaders

discovered that a firm with a 20% operating margin can see as big an increase in value by cutting

costs, one billion dollars as it can by increasing revenue by five billion dollars.

For all the complaints from Musk critics about a buggy site, quote, on the precipice of crashing,

unquote, he's maintained a minimum viable product while shedding four in five employees in six

...